Oxazepam
Short-acting 3-hydroxy benzodiazepine. Both a clinical drug (Serax) AND the terminal active metabolite of the diazepam/clorazepate/chlordiazepoxide cascade. Primarily glucuronidated (no CYP) → safe in hepatic impairment.
Projected serum levels — 15 mg, twice daily
Maintenance schedule: 15 mg twice daily (oral).
Loading schedule: 24.1 mg on day 1, then 15 mg twice daily — reaching therapeutic levels sooner.
Modeled steady state after ~2 days: peak ≈ 18.1 mg, trough ≈ 8.2 mg body load. Population-based estimate over 15 days for a 15 mg dose at a 70 kg reference body mass — the interactive app scales curves to your doses, timing, and body mass.
Key facts
- Category
- Benzodiazepine
- Route modeled
- Oral
- Model confidence
- inferred
- Half-life
- 8 h
- Common dose
- 15 mg
- Suggested maximum
- 60 mg/day
- Reference dose range
- 7.5–60 mg (single dose)
- Suggested cadence
- twice daily
- Validated against
- 15 mg oral — Cmax 0.40 mg/L at 2.5 h
Documented interactions
-
watch
GABA (Gamma-Aminobutyric Acid) + Oxazepam
GABA (Gamma-Aminobutyric Acid) and Oxazepam both push the gaba a in the same direction.
-
watch
Ivermectin (Stromectol) + Oxazepam
Ivermectin (Stromectol) and Oxazepam both push the gaba a in the same direction.
-
watch
L-Theanine + Oxazepam
L-Theanine and Oxazepam both push the gaba a in the same direction.
-
watch
Taurine + Oxazepam
Oxazepam and Taurine both push the gaba a in the same direction.
Serum checks 4 modeled interaction pairings for oxazepam across your whole stack — absorption conflicts, enzyme inhibition, and nutrient depletion included.